Medical Affairs

Innoviva Specialty Therapeutics has created this website as a tool for healthcare professionals in the United States. The information presented on this platform is solely for informational purposes and is not meant to advertise or endorse the use of any particular product.

For medical inquiries, please contact medinfo@istx.com.

Medical Information Request

If you have a question about an Innoviva Specialty Therapeutics product and would like to speak with a medical information specialist, please call 1-800-651-3861 (Monday to Friday, 9 AM to 5 PM ET, excluding holidays) or email medinfo@istx.com. If you have a medical emergency, dial 911 for immediate assistance.

Our marketed products are GIAPREZA® (angiotensin II) and XERAVA® (eravacycline)

Our investigational therapies are Sulbactam-durlobactam and Zoliflodacin

Publications

For publications about products, please visit the links below:

GIAPREZA® (angiotensin II)
View publications

XERAVA® (eravacycline)
View publications

Sulbactam-durlobactam
View publications

Zoliflodacin
View publications

Request Follow-up from a Medical Science Liaison

If you would like additional information about our products or would like to discuss research ideas, please contact medinfo@istx.com.

Report an Adverse Event

To report an Adverse Event, please use the appropriate product contact below. You can also contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

To report an Adverse Event for XERAVA® (eravacycline):
Email tphasemedinfo@ljpc.com or call us 1-833-7-XERAVA (1-833-793-7282)

To report an Adverse Event for GIAPREZA® (angiotensin II):
Email medicalinformation@ljpc.com or call us 1-800-651-3861